Primary liver cancer organoids and their application to research and therapy
Open Access
- 17 June 2024
- journal article
- review article
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 4 (3) , 195-202
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (ZIA BC 011888)
This publication has 76 references indexed in Scilit:
- Organoid assessment technologiesClinical and Translational Medicine, 2023
- In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bedAngiogenesis, 2022
- Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironmentBiomaterials, 2022
- Patient‐derived organoids for personalized gallbladder cancer modelling and drug screeningClinical and Translational Medicine, 2022
- Modeling hepatoblastoma development with human fetal liver organoids reveals YAP1 activation is sufficient for tumorigenesisProtein & Cell, 2021
- Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapyActa Pharmaceutica Sinica B, 2021
- Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsCancer Cell, 2021
- Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer researchCancer Letters, 2021
- Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in MiceThe American Journal of Pathology, 2018
- Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potentialInternational Journal of Cancer, 2015